These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19409694)

  • 21. [Correction of erectile dysfunction in patients with benign prostate hyperplasia using daily administration of tadalafil 5 mg against the background of combined drug therapy].
    Volkov AA; Petrichko MI; Budnik NV
    Urologiia; 2013; (5):50-2, 54. PubMed ID: 24437241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Incrocci L; Slagter C; Slob AK; Hop WC
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):439-44. PubMed ID: 16965992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries.
    Mirone V; Costa P; Damber JE; Holmes S; Moncada I; Van Ahlen H; Wespes E; Cordell WH; Chan M; Lembo D; Varanese L
    Eur Urol; 2005 Jun; 47(6):846-54; discussion 854. PubMed ID: 15925082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of erectile dysfunction with chronic dosing of tadalafil.
    McMahon CG
    Eur Urol; 2006 Aug; 50(2):215-7. PubMed ID: 16844542
    [No Abstract]   [Full Text] [Related]  

  • 26. Daily Tadalafil: line extension. Beware medicalisation of human existence.
    Prescrire Int; 2008 Aug; 17(96):142. PubMed ID: 19480097
    [No Abstract]   [Full Text] [Related]  

  • 27. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
    Young JM; Feldman RA; Auerbach SM; Kaufman JM; Garcia CS; Shen W; Murphy AM; Beasley CM; Hague JA; Ahuja S
    J Androl; 2005; 26(3):310-8. PubMed ID: 15866997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial comment.
    Kaplan SA
    Urology; 2010 Jun; 75(6):1458-9. PubMed ID: 20513509
    [No Abstract]   [Full Text] [Related]  

  • 29. An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study.
    Hellstrom WJ; Gittelman M; Jarow J; Steidle C; McMurray J; Talley D; Watts S; Mitchell CL; McGill JM
    Eur Urol; 2008 May; 53(5):1058-65. PubMed ID: 17945409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daily use of phosphodiesterase 5 inhibitors for erectile dysfunction and lower urinary tract symptoms.
    Pimentel H; Wald M; Niederberger C
    Int J Impot Res; 2008; 20(2):145-9. PubMed ID: 18075506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tadalafil in patients with benign prostatic hyperplasia during conservative combined therapy].
    Volkov AA; Petrichko MI; Budnik NV; Dukhin AR
    Urologiia; 2013; (2):56, 58-9. PubMed ID: 23789365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds.
    Wong P; Lawrentschuk N; Bolton DM
    Curr Opin Urol; 2009 Jan; 19(1):7-12. PubMed ID: 19057210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tadalafil for treatment of erectile dysfunction in men on antidepressants.
    Segraves RT; Lee J; Stevenson R; Walker DJ; Wang WC; Dickson RA
    J Clin Psychopharmacol; 2007 Feb; 27(1):62-6. PubMed ID: 17224715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy.
    Mirone V; Imbimbo C; Rossi A; Sicuteri R; Valle D; Longo N; Fusco F;
    Asian J Androl; 2007 May; 9(3):395-402. PubMed ID: 17486281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tadalafil: a new agent for erectile dysfunction.
    Brock GB
    Can J Urol; 2003 Feb; 10 Suppl 1():17-22. PubMed ID: 12625846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials.
    Shabsigh R; Burnett AL; Eardley I; Sharlip ID; Ellsworth PI; Garcia CS; Natanegara F; Ahuja S
    BJU Int; 2005 Oct; 96(6):857-63. PubMed ID: 16153217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterase-5 inhibitors for lower urinary tract symptoms in men.
    Gales BJ; Gales MA
    Ann Pharmacother; 2008 Jan; 42(1):111-5. PubMed ID: 18094344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study.
    Aversa A; Greco E; Bruzziches R; Pili M; Rosano G; Spera G
    Int J Impot Res; 2007; 19(2):200-7. PubMed ID: 16943794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic PDE-5 inhibition in patients with erectile dysfunction - a treatment approach using tadalafil once-daily.
    Porst H; Hell-Momeni K; Büttner H
    Expert Opin Pharmacother; 2012 Jul; 13(10):1481-94. PubMed ID: 22725705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Phosphodiesterase inhibitors: effectiveness and new applications].
    van Driel MF
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1613-6. PubMed ID: 16901064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.